Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Miyuki Nishikawa"'
Autor:
Akihiro Kawamoto, Takayuki Kato, Keiichi Namba, Takuma Toyonaga, Makoto Miyata, Daisuke Nakane, Miyuki Nishikawa
Publikováno v:
mBio, Vol 10, Iss 6 (2019)
mBio, Vol 10, Iss 6, p e02846-19 (2019)
mBio
mBio, Vol 10, Iss 6, p e02846-19 (2019)
mBio
The genus Mycoplasma is made up of the smallest parasitic and sometimes commensal bacteria; Mycoplasma pneumoniae, which causes human “walking pneumonia,” is representative. More than ten Mycoplasma species glide on host tissues by novel mechanis
Autor:
Miyuki Nishikawa
Publikováno v:
Modern Physics Letters A. 18:1991-1999
In usual dimensional counting, momentum has dimension one. But a function f(x), when differentiated n times, does not always behave like one with its power smaller by n. This inevitable uncertainty may be essential in general theory of renormalizatio
Autor:
Shunji Suzuki, Midori Kotake, Asami Fujikawa, Yukie Kasahara, Miyuki Nishikawa, Yurina Wada, Sanae Kanai
Publikováno v:
Journal of Clinical Gynecology and Obstetrics. 4:235-236
Autor:
Mikio Yamamoto, Takuhiko Akatsu, Katsuhiro Ono, Naokazu Nagata, Kazuo Motoyoshi, Takehiko Murakami, Michiko Yamamoto, Miyuki Nishikawa
Publikováno v:
Biochemical and Biophysical Research Communications. 252:747-752
Osteoclastogenesis inhibitory factor (OCIF), also termed osteoprotegerin (OPG), is a secreted member of the tumor necrosis factor (TNF) receptor family. It inhibits bone resorption in vivo and osteoclast-like cell (OCL) formation in vitro. To better
Autor:
Nariyoshi Shinomiya, Takehiko Murakami, Miyuki Nishikawa, Kanji Higashio, Kyoji Yamaguchi, Takuhiko Akatsu, Michiko Yamamoto, Eisuke Tsuda, Kazuo Motoyoshi, Katsuhiro Ono, Shinichi Mochizuki, Naokazu Nagata, Masahiko Kinosaki
Publikováno v:
Biochemical and Biophysical Research Communications. 250:229-234
Osteoclastogenesis inhibitory factor (OCIF) was originally identified as a factor inhibiting osteoclast (OC) formation. The number of OC in rats treated with OCIF decreased, suggesting that OCIF inhibits OC formation in vivo; however, it is also poss
Autor:
Kanji Higashio, Takuhiko Akatsu, Naokazu Nagata, Kazuo Motoyoshi, Michiko Yamamoto, Eisuke Tsuda, Miyuki Nishikawa, Shinichi Mochizuki, Takehiko Murakami
Publikováno v:
Endocrinology. 139:4012-4015
Osteoclastogenesis inhibitory factor (OCIF), also termed as osteoprotegerin (OPG), is a soluble member of the tumor necrosis factor receptor family. Although OCIF/OPG is shown to inhibit osteoclast formation in vitro and prevent ovariectomy-induced b
Autor:
Michiko Yamamoto, Yoshikazu Takada, Naokazu Nagata, Takuhiko Akatsu, Takehiko Murakami, Nobuo Kugai, Katsuhiro Ono, Miyuki Nishikawa, Yasuyuki Katayama, Nariaki Matsuura, Seiki Wada
Publikováno v:
Journal of Bone and Mineral Research. 13:1251-1259
It is reported that Chinese hamster ovary cells transfected with human alpha4 cDNA (alpha4CHOs) and expressing functional alpha4beta1 integrin developed bone metasasis in nude mice. To clarify the role of alpha4beta1 integrin in bone metastasis, in t
Autor:
Miyuki Nishikawa, Mikio Yamamoto, Takehiko Murakami, Seiki Wada, Katsuhiro Ono, Takuhiko Akatsu, Naokazu Nagata, Nariaki Matsuura, Nobuo Kugai
Publikováno v:
Bone. 23:27-32
We recently reported that numerous osteoclasts (OC) were formed in cocultures of some mouse cancer cell lines and bone marrow cells. In this study, we examined mechanisms by which one of the cell lines, BALB/c-MC, induces OC. BALB/c-MC dose dependent
Autor:
Miyuki Nishikawa, Michiko Yamamoto, Takehiko Murakami, Naokazu Nagata, Takuhiko Akatsu, Nobuo Kugai
Publikováno v:
Journal of Bone and Mineral Research. 13:986-995
The theory that bisphosphonates inhibit osteoclast formation through their effects on osteoblastic cells remains controversial. To confirm the inhibitory effect of bisphosphonates on osteoclast formation and gain some insights into the underlying mec
Autor:
Yasuyuki Katayama, Katsuhiro Ono, Tatsuya Tamura, Nobuo Kugai, Naokazu Nagata, Takuhiko Akatsu, Michiko Yamamoto, Miyuki Nishikawa
Publikováno v:
Journal of Bone and Mineral Research. 13:400-408
Osteoclastic bone resorption increases at the site of bone metastasis, but little is known about how tumor cells induce osteoclast (OC) recruitment in the bone marrow microenvironment. To clarify this point, we examined the effects of various mouse t